<DOC>
	<DOCNO>NCT01683006</DOCNO>
	<brief_summary>The purpose study evaluate impact muscle relax drug energy rate hypothermia cardiac arrest .</brief_summary>
	<brief_title>Influence Skeletal Muscle Paralysis Metabolism Hypothermic Patients After Cardiac Arrest</brief_title>
	<detailed_description>Mild hypothermia improve neurological outcome cardiac arrest . Neuromuscular blocker use , together analgesia sedation , cool process many center prevent shiver . However , neuromuscular blocker accuse associate various side effect cause serious harm and/or lead prolonged ICU stay . Furthermore , use neuromuscular blocker may mask epileptic activity . Therefore , advantage disadvantage neuromuscular blocker therapeutic hypothermia need re-evaluated . Aim study investigate continuous application neuromuscular blocker necessary prevent shiver thereby avoid increase energy expenditure patient therapeutic hypothermia rewarming cardiac arrest ( initial 72h ) .</detailed_description>
	<mesh_term>Heart Arrest</mesh_term>
	<mesh_term>Critical Illness</mesh_term>
	<mesh_term>Paralysis</mesh_term>
	<mesh_term>Hypothermia</mesh_term>
	<mesh_term>Rocuronium</mesh_term>
	<mesh_term>Neuromuscular Blocking Agents</mesh_term>
	<criteria>All patient receive mild therapeutic hypothermia cardiac arrest presume cardiopulmonary origin age &lt; 18 cardiac arrest &gt; 6 hour admittance hospital patient know clinically apparent pregnancy patient reach hospital body temperature 35Â°C patient know allergic reaction rocuronium patient history myasthenia gravis patient obvious intoxication ward state/prisoners patient know epileptic disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>